ANTHONY MARESSO to Anti-Bacterial Agents
This is a "connection" page, showing publications ANTHONY MARESSO has written about Anti-Bacterial Agents.
Connection Strength
1.666
-
The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024 Dec 12; 12(1):eesp00292023.
Score: 0.360
-
Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
Score: 0.299
-
Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
Score: 0.284
-
Escherichia coli Free Radical-Based Killing Mechanism Driven by a Unique Combination of Iron Restriction and Certain Antibiotics. J Bacteriol. 2015 Dec; 197(23):3708-19.
Score: 0.203
-
Sortase as a target of anti-infective therapy. Pharmacol Rev. 2008 Mar; 60(1):128-41.
Score: 0.120
-
Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
Score: 0.101
-
A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
Score: 0.089
-
Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
Score: 0.087
-
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
Score: 0.077
-
Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child. J Pediatr. 2026 Apr; 291:115005.
Score: 0.026
-
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. mSphere. 2022 08 31; 7(4):e0034522.
Score: 0.020